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ORIGINAL ARTICLE
Endophytes: exploiting biodiversity for the improvement of natural product-based drug discovery
Agata Staniek, Herman J. Woerdenbag and Oliver Kayser*
Pharmaceutical Biology Department, University of Groningen, The Netherlands
(Received 12 November 2007; final version received 28 December 2007)
Endophytes, microorganisms that colonize internal tissues of all plant species, create a huge biodiversity with yet
unknown novel natural products, presumed to push forward the frontiers of drug discovery. Next to the clinically
acknowledged antineoplastic agent, paclitaxel, endophyte research has yielded potential drug lead compounds
with antibacterial, antiviral, antioxidant, insulin mimetic, anti-neurodegenerative and immunosuppressant
properties. Furthermore, while being implicated in livestock neurotoxicosis, some endophyte-produced alkaloids
have been shown to display insecticidal activity. The endophyte-host relationship is postulated to be a ‘balanced
antagonism’. Moreover, the plausibility of horizontal gene transfer (HGT) hypothesis is taken into account.
Knowledge of the genetic background of endophytic natural product biosynthesis is discussed on the basis of
loline alkaloids, ergopeptines, lolitrems and maytansinoids. The current dynamic progress in genomics will
contribute to a better understanding of endophytic microbes and to further exploiting them as a source of
pharmaceutically relevant compounds.
Keywords: endophyte; natural product; drug discovery; plant-microbe interactions
Introduction
Endophyte (Gr. endon, within; phyton, plant)  the
term was first coined by de Bary (de Bary 1866) and
has become deeply embedded in the literature ever
since. At present, endophytic organisms are defined
as ‘microbes that colonize living, internal tissues of
plants without causing any immediate, overt negative
effects’ (Stone et al. 2000). First reports describing
these microbes date back to the turn of the nineteenth
and twentieth century (Freeman 1904). The most
frequently encountered endophytes are representa-
tives of the fungi; however, the existence of many
endophytic bacteria has been documented as well.
Of the nearly 300,000 plant species inhabiting our
planet, each individual one is host to several to
hundreds of endophytes (Tan and Zou 2001), creating
an enormous biodiversity: a myriad of undescribed
species, a rich source of novel natural products
therefrom and an unknown genetic background of
all the interdependencies thus implied.
Several reviewers addressed the issue (e.g. Tan
and Zou 2001; Strobel and Daisy 2003; Owen and
Hundley 2004; Schulz and Boyle 2005; Gunatilaka
2006), shedding light onto selected aspects of the
nature of endophytes. The aim of the hereby pre-
sented study is to render a comprehensive overview of
the current knowledge on the subject. Considerable
emphasis is put on the role and potential of metabolic
engineering (Tyo et al. 2007) and combinatorial
biosynthesis (Floss 2006), as well as on their impact
on exploiting the astounding diversity of the endo-
phytic world for its pharmaceutical potential.
Endophytes as biological factories of functional
metabolites
Endophytic natural products as drugs and novel drug
leads
It seems impossible to underestimate the impact of
natural products on the drug discovery process. Even
with lack of support from the major pharmaceutical
companies, arguing that the natural product screening
paradigm established in the late 1980s and early 1990s
was no longer compatible with the HTS (high-
throughput screening) approach, the significance of
secondary metabolites as a source of novel drugs and
drug-leads is still alive and well. Over 20 natural-
product-derived drugs have been launched onto the
worldwide market from 20012005 and around 140
have undergone various stages of clinical development
in all major therapeutic areas (Butler 2005; Lam 2007).
The recent development and implementation of
new technologies offers unique opportunities in the
screening of natural products and will re-establish
them as a major source for drug discovery. Improved
natural product sourcing, aiming at narrowing the
focus from all available sources to a single most
prolific and reliable one, points to microorganisms as
the ultimate, readily renewable, reproducible and
inexhaustible source of novel structures bearing
pharmaceutical potential. It is believed that up to
99% of microorganisms have yet to be discovered
(Davis et al. 2005). This undefined richness of
microbial world encompasses the plethora of endo-
phytic entities occupying utterly millions of unique
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biological niches (higher plants) in various, many a
time unusual, environments (Strobel 2006).
Functional metabolites of endophytic origin have
already demonstrated a considerable potential to
impact the pharmaceutical arena (Tan and Zou
2001; Strobel 2003; Strobel and Daisy 2003; Strobel
et al. 2004; Gunatilaka 2006). A few examples are
presented in this section, with the focus on their
presumed therapeutic significance.
As the anti-infective branch is experiencing a
shortage of lead compounds progressing into clinical
trials, new antibacterial templates with novel mechan-
isms of action should have advantages over known
antibiotics, especially in the fight against multi-drug
resistant bacteria and emerging pathogens. Guana-
castepene (Figure 1), a novel diterpenoid produced by
a fungus isolated from the branch of Daphnopsis
americana growing in Guanacaste, Costa Rica, might
prove a representative of a potentially new class of
antibacterial agents, showing activity against methi-
cillin-resistant Staphylococcus aureus and vancomy-
cin-resistant Enterococcus faecium (Singh et al. 2000).
Although apparently the potential for the discov-
ery of endophytic compounds having antiviral activ-
ity is in its infancy, probably due to absence of
appropriate antiviral screening systems in most
compound discovery programmes, some promising
fungal metabolites have been found. Initially, two
novel tridepside human cytomegalovirus (hCMV)
protease inhibitors, cytonic acids A and B were
isolated from Cytonaema sp. inhabiting the internal
tissues of Quercus sp. (Guo et al. 2000). Further
studies of the microbial flora characteristic of oak
trees resulted in the isolation of a potentially valuable
fungal specimen from the leaves of Quercus coccifera.
This endophyte proved to be a synthesizer of
hinnuliquinone (Figure 2)  a potent inhibitor of
the HIV-1 protease (Singh et al. 2004).
Two isobenzofuranones, pestacin and isopestacin
(Figure 3), with structural similarity to the flavonoids
 a well-established group of free-radical-scavengers,
proved to exceed the anti-oxidant activity of trolox
(a vitamin E derivative) by at least one order of
magnitude, as measured by the total oxyradical
scavenging capacity (TOSC) assay. These new potent
antioxidants were obtained from Pestalotiopsis micro-
spora, an endophyte of Terminalia morobensis inha-
biting the Sepik River drainage of Papua New
Guinea (Strobel et al. 2002; Harper et al. 2003).
Pseudomassaria sp., a fungal endophyte recovered
from leaves of an undetermined plant collected near
Kinshasa, Democratic Republic of Congo, was
shown to be a biofactory of nonpeptidal insulin
mimetic, L-783,281 (Figure 4). Its discovery
prompted quite a revolutionary notion in the therapy
of diabetes, namely: an orally administered activator
of the human insulin receptor (Zhang et al. 1999).
Moreover, this intriguing endophytic metabolite
was reported capable of stimulating the Trk family of
tyrosine kinase receptors, leading to the activation of
multiple signalling cascades, culminating in neuro-
regenerative effects, including neuronal survival and
neurite outgrowth (Wilkie et al. 2001). Although the
cytotoxicity of the compound seems to preclude its
direct therapeutic application, it is a prototype for
small molecule insulin and neurotrophin mimetics,
and may lead to the development of pharmaceutically
significant compounds for the treatment of diabetes
and neurodegenerative disorders.
Following the track of search for new immuno-
suppressants from endophytes resulted in the isola-
tion of subglutinol A (Figure 5) and B. These
diterpene pyrones from Fusarium subglutinans, har-
bored by the perennial twining vine Tripterygium
wilfordii, showed substantial immunosuppressive ac-
tivity while causing none of the detrimental cytotoxic
effects characteristic of cyclosporine A (Lee et al.
1995; US Patent 5648376, 1997).
Amongst the bioactive natural products of en-
dophytic origin described to date, the ones notable
for their antitumor activity seem to have drawn quiteFigure 1. Guanacastepene.
Figure 2. Hinnuliquinone.
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an unequivocal attention, with paclitaxel (Taxol) as
the most striking example (Figure 6).
Since its discovery in the 1960s, through structure
elucidation completed in 1971 and FDA approval in
1992, this highly functionalized diterpenoid natural
product has evolved to become a blockbuster drug
with commercial sales of well over $3 billion in 2004
(Croteau 2005). Since it was primarily obtained from
the inner bark of Taxus brevifolia, a relatively rare
and slow-growing tree, the supply of this potent
antineoplastic agent was soon to become the issue of
scarcity, as even early estimations indicated that the
demand for paclitaxel might exceed 300 kg, which
would amount to 750,000 yew trees per year (Stierle
et al. 1995). The supply crisis, as well as the ecological
implications resulting in the plant-endangered status,
prompted the search for paclitaxel-producing micro-
organisms among the endophytic fungi of Taxus.
While the 1990s brought quite an abundance of
reports on paclitaxel-producing endophytes (e.g.
Stierle et al. 1993; Strobel et al. 1996, 1997; Li et al.
1998a, b; Noh et al. 1999; Zhou and Ping 2001), no
conclusive follow-up data concerning fungal metabo-
lite profile or genetic background of the biosynthetic
pathway leading to paclitaxel in fungi is available at
present. While the pursuit of the idea of a microbial
paclitaxel source, providing for an inexhaustible
supply of this antineoplastic blockbuster and novel
taxanes, is being hampered by obtaining disappoint-
ingly low yields, the active ingredient is still mainly
derived via chemical semisynthesis from the advanced
taxoid, 10-deacetylbaccatin III, readily available from
the needles of the European yew tree, Taxus baccata,
being a renewable source and, to a lesser extent, by
means of plant cell culture methods (Leistner 2005;
Frense 2007). Nonetheless, the exciting progress that
has been made in the elucidation of biosynthetic route
leading to paclitaxel in planta due to fundamental
works of Croteau and his co-workers (Walker and
Croteau 2001; Jennewein et al. 2004a, b; Croteau
2005; DeJong et al. 2006; Nims et al. 2006), as well as
the recent advances in microbial genomics (Zazopou-
los et al. 2003; Stephanopoulos et al. 2004; Keller
et al. 2005; van Lanen and Shen 2006) and combina-
torial biosynthesis (Floss 2006; Nguyen 2006; Klein-
Marcuschamer et al. 2007), might still revive and
boost the interest in endophytic paclitaxel synthesi-
zers.
Agricultural aspects: endophytic insecticides vs.
tremorgenic mycotoxins
As the world becomes wary of ecological damage
done by synthetic insecticides, endophytic research
Figure 3. Pestacin (a) and Isopestacin (b).
Figure 4. L-783,281. Figure 5. Subglutinol A.
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continues for the discovery of powerful, selective and
safer alternatives (Strobel and Daisy 2003).
From 19301970 millions of hectares in the
temperate transition zone of the south central and
southeastern USA were converted from revegeta-
tion shrubs and weeds to pastures of tall fescue
(Festuca arundinacea). This grass was superior
forage to native flora, but it was soon noticed
that the expected livestock productiveness was not
being met. An associated complex of symptoms
episodically suffered by grazing livestock was
termed ‘tall fescue toxicosis’ and consequently led
to considerable economic losses to the US beef
industry (Hoveland 1993; Thompson and Stuede-
man 1993). Simultaneously, the livestock grazing
on perennial ryegrass (Lolium perenne) pastures in
New Zealand was afflicted by ‘ryegrass staggers’
(Gallagher et al. 1984; Bush et al. 1997). These
problems spurred intense research that led to the
isolation and identification of two respective fungal
endophytes: Neotyphodium coenophialum and Neo-
typhodium lolii, both phylogenetically related to the
ergot fungus Claviceps purpurea (Kuldau et al.
1997). Thus, the said endophytes were implicated
in the associated livestock toxicoses, but both also
greatly enhanced fitness of their plant hosts under
biotic and abiotic stresses. Further investigation of
the genus Neotyphodium (sexual state: Epichloe¨)
proved its representatives capable of synthesizing
four groups of alkaloids. Of these, the ergot
alkaloids and tremorgenic lolitrems cause neuro-
toxic effects on grazing or granivorous vertebrates
(Steyn and Vleggaar 1985; Bacon et al. 1986).
Peramine is an insect feeding deterrent and protects
perennial ryegrass from the Argentine stem weevil,
Listronotus bonariensis, a highly destructive insect
pest in New Zealand (Rowan and Latch 1994;
Tanaka et al. 2005). Lolines are potent insecticidal
and anti-aphid agents, not being implicated in any
mammalian toxicoses (Jackson et al. 1996; Wilk-
inson et al. 2000). Obviously, the last of the
aforementioned groups of alkaloids should provide
for the most promising candidates to aid the
agricultural arena.
As the forage grasses associated endophytes seem
to constitute an extensively investigated and well
documented microbial group (see further sections),
they might prove to become a platform for the
endophyte research to advance to the next level of
modern microbial genomics and systems biology
(Stephanopoulos et al. 2004; van Lanen and Shen
2006).
Endophyte vs. host: the relationship
A conflict of interests?
Over the years, despite the controversy it seemed to
have aroused in the early 1990s (Wennstro¨m 1994),
the term ‘endophyte’ has evolved from its original
suggested definition, which described merely the
location, to depict the nature of the association
between the microbe and the host-plant (Wilson
1995). To truly define the interaction, however,
seems to be quite a task. In fact, it can vary in a
seamless manner from mutualism to parasitism,
based on a fine-tuned balance between the demands
of the invader and the plant response (Kogel et al.
2006).
A very elegant hypothesis has been proposed and
extensively documented by Schulz and Boyle (2005),
postulating the relationship to be a ‘balanced antag-
onism’ (Figure 7).
The said notion can be deciphered as equilibrium,
under environmental, physiological and genetic con-
trol, that results in fitness benefits for both partners.
On one hand, the theory depicts fungal endophytes as
‘masters of phenotypic plasticity’, able to infect as
endosymbionts, to colonize cryptically, and finally to
sporulate as pathogens or saprophytes. This creative
variability implies evolutionary potential. On the
other hand, it does not exclude the possibility of
secondary metabolites being a contribution of the
endophytic partner to a mutualistic relationship. A
very interesting example of the protective power of an
endophyte involves the aquatic plant Rhyncholacis
penicillata collected from a river system in Southwest
Venezuela where the harsh aquatic environment
subjected the plant to constant beating by virtue of
rushing waters, debris, and tumbling rocks and
pebbles. Such circumstances should provide ample
opportunity for pathogenic oomycetes to invade the
plant. Still, the plant population remained quite
healthy. Upon extraction and investigation of the
endophytic flora of R. penicillata, a potent anti-
fungal bacterium, Serratia marcescens, was identified,
which in turn was shown to produce oocydin A
(Figure 8), a novel anti-oomycetous compound that
obviously provided the plant with the requisite
protection from the water molds (Strobel et al. 1999).
Recently, it has been hypothesized that endo-
phytes may protect their host plants by scavenging
the damaging reactive oxygen species (ROS) gener-
ated by the plant defence mechanisms in response to
Figure 6. Paclitaxel.
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environmental stress (Rodriguez and Redman 2005;
Tanaka et al. 2006). Thus, a strong activation of ROS
due to biotic and abiotic stresses on part of the host
followed by an equally rapid free-radical-scavenging
response of the microbe might potentially be a prime
mechanism in maintaining the delicate balance be-
tween the two.
To address the question asked in the title of this
section: there is always a ‘conflict of interests’ at all
stages of relationships between endophytic and plant
partners (Smith and Read 1997). However, the
development of tools for non-invasive observation
of subcellular activities during the establishment of
mutualistic interactions will provide a deeper under-
standing of the mechanism that balances virulence
against defence; hostility against hospitality (Kogel et
al. 2006).
A relationship within a relationship
While fungal viruses have been shown capable of
modulating plant-fungal symbioses by regulating the
hypovirulence of pathogenic fungi (e.g. Ahn and Lee
2001; Dawe and Nuss 2001), the effect of mycoviruses
on mutualistic fungal endophytes has not been
described. But one report of a mycovirus from the
well-known endophytic microbe, Epichloe¨ festucae,
was recorded (Zabalgogeazcoa et al. 1998). Still, no
decisive phenotypic traits have been associated with
this virus since.
However, a very recent study reports a complex
tripartite symbiosis involving a virus, a fungal
endophyte and a plant (Ma´rquez et al. 2007). Thus
far it was believed that the mutualistic relationship
between a tropical panic grass from geothermal soils,
Dichanthelium lanuginosum, and the fungus Curvu-
laria protuberata, allowed both organisms to grow at
high soil temperatures in Yellowstone National Park
(Redman et al. 2002). The in-depth investigation of
this beneficial interaction showed, however, that the
ability of the fungus to confer heat tolerance to its
host plant is, in fact, related to a presence of yet
another kind. To reflect its host of origin and its
unique phenotype the responsible mycovirus was
named Curvularia thermal tolerance virus (CThTV).
A physical interaction merely? The plausibility of
horizontal gene transfer (HGT) hypothesis
While enthusiasts call it ‘the essence of the phyloge-
netic process and the driving force in a new paradigm
for evolution’ (Doolittle 1999), sceptics describe it as
no more than one of many phylogenetic anomalies
(Kurland et al. 2003). Though highly controversial,
the hypothesis of horizontal gene transfer seems quite
seductive.
Hereby, two intriguing examples from the endo-
phytic world are discussed. Both instances deal with
the occurrence of identical natural products in
unrelated taxa, namely: the host and the invader.
The presence of maytansinoids, potent cytotoxic
agents, was first noticed in the Ethiopian shrub,
Maytenus serrata (Kupchan et al. 1972). Further
investigation recorded their occurrence not only in
higher plants (Wani et al. 1973; Ahmed et al. 1981;
Powel et al. 1982), but also in mosses (Sakai et al.
1988; Suwanborirux et al. 1990) and, remarkably, in
gram-positive Actinomycetes (Higashide et al. 1977;
Asai et al. 1978). One could assume that the
biosynthesis of these unique natural products has
Figure 7. Balanced antagonism hypothesis (Schulz and Boyle 2005).
Figure 8. Oocydin A.
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been repeatedly invented during evolution. However,
the fact that approximately 48 genes are involved in
the bacterial synthesis of maytansinoids (Yu et al.
2002) makes it highly unlikely. Similarly, the afore-
mentioned ubiquity of paclitaxel occurrence in yews
as well as in taxonomically distant fungal microbes
raises questions. Therefore, it seems possible that in
the course of evolution a lateral (horizontal) gene
transfer took place between different, taxonomically
unrelated species, thus explaining the distant distri-
bution of the antineoplastic secondary metabolites
mentioned above between pro- and eukaryotes.
Nevertheless, before invoking HGT, alternative
and often equally plausible, explanations ought to be
thoroughly considered. In case of maytansinoids, all
evidence seems to point to them being ultimately
produced by plant associated microorganisms. May-
tansine, the unique parent compound (Figure 9), was
found neither in cell suspension cultures from May-
tenus buchananii (Kutney et al. 1981) nor in callus
cultures raised from Maytenus wallichiana (Dy-
mowski and Furmanowa 1990) and Putterlickia
verrucosa (Pullen et al. 2003).
This is in line with the result of an in-depth search
for the unique gene involved in maytansinoid bio-
synthesis, encoding for 3-amino-5-hydroxybenzoic
acid (AHBA) synthase, in Putterlickia verrucosa cell
cultures. An extensive PCR based homology screen
gave negative results only (Pullen et al. 2003). These
observations point to the conclusion that plants do
not produce maytansinoids ab initio. However, an
active role of the plant in an overall biosynthesis
cannot be excluded, as it seems likely that the host
converts a bacterially synthesized precursor into the
final, biologically active compound. Secondly, it is
possible that maytansine is only produced as a
consequence of a pathogen attack on the plant. The
plants may contain a biologically inactive bacterially
produced precursor, which is only converted into the
potent final product in response to a signal resulting
from the attack. Alternatively, and more plausibly,
the bacterial production of the maytansinoid pre-
cursor could be triggered by a plant signal in response
to the pathogen aggression (Cassady et al. 2004).
On the contrary, the bio-formation of paclitaxel
seems to be a genuine feature of the yew host, as ample
evidence supporting the production of the diterpenoid
by sterile cell suspension cultures of Taxus has been
provided (e.g. Ketchum and Gibson 1996; Ketchum
and Croteau 1998; Yukimune et al. 2000; Wu and Lin
2003; Naill and Roberts 2005; Khosroushahi et al.
2006; Vongpaseuth and Roberts 2007). This conclu-
sion is further supported by the aforementioned work
of Croteau and his associates who succeeded in the
isolation of paclitaxel biosynthetic genes of plant
origin. Interestingly, the taxadiene synthase gene has
a long N-terminal targeting sequence for localization
to and processing in the plastids, indicating that this
gene is plant-derived rather then a fungal product
(Koepp et al. 1995; Walker and Croteau 2001).
Accordingly, an extensive PCR-based screen for
taxadiene synthase gene in Taxomyces andreanae,
the very first presumed endophytic taxane-producer
(Stierle et al. 1993), failed to provide for any positive
results (Staniek, unpublished data).
To sum up, the evidence for lateral gene transfer
in eukaryotes remains largely anecdotal (Rosewich
and Kistler 2000). However tempting and attractive,
the HGT hypothesis has to give way to a more
plausible alternative postulating the endophyte-host
co-evolution.
Investigating the genetic background of endophytic
biosynthetic pathways: identification, molecular
cloning, genetic analysis and manipulation of
endophytic gene clusters
Clusters of functionally related genes are a general
feature of prokaryotic gene organization, but were
believed to be much less prevalent in eukaryotes.
However, the advent of recombinant DNA meth-
odologies in the 1980s enabled dramatic progress in
the genetics and biochemistry of fungal secondary
metabolism. This rapid progress was facilitated by
what is now considered a hallmark characteristic of
secondary metabolic biosynthetic pathways  the
grouping of pathway genes in a contiguous cluster
(Keller and Hohn 1997; Keller et al. 2005).
The balansiaceous endophytes and their natural
products
The balansiaceous endophytes form a unique group
of closely related fungi with ecological requirements
and adaptations distinct from those of other endo-
phytes (Petrini 1996). They belong to the clavicipitac-
eous genera Epichloe¨ and Balansia, and their
anamorphs Neotyphodium and Ephelis (Schardl
et al. 2004).
As previously stated, due to their ecological and
economic impact, theirs seems to be the best studied
group of endophytes. The following section focusesFigure 9. Maytansine
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on the recent advances in dissecting the molecular
mechanisms driving the biosynthesis of their second-
ary metabolites.
Loline alkaloids (LA)
Unique not only in structure, comprising a saturated
1-aminopyrrolizidine-ring system, with a highly
strained ether bridge between C-2 and C-7
(Figure 10) (Petroski et al. 1989), but also due to
their potent, broad-spectrum insecticidal activities
(Jackson et al. 1996; Wilkinson et al. 2000), loline
alkaloids have remained a biosynthetic enigma till
very recently (Blankenship et al. 2005).
Establishing that the production of lolines in
axenic cultures of Neotyphodium uncinatum can be
regulated by culture conditions (Blankenship et al.
2001), which in turn suggests differential expression of
genes involved in LA biosynthesis, prompted a notion
that the isolation of the genes up-regulated during
loline production could be a first step in identifying
possible enzymes catalyzing their biosynthesis. The
recent development of novel highly effective methods
for identifying differentially expressed transcripts,
enabled the application of suppression subtractive
hybridization technique (Diatchenko et al. 1996,
1999) and provided for a successful identification of
two genes, lolA and lolC, associated with endophytic
loline synthesis (Spiering et al. 2002).
These encouraging results spurred intense re-
search on the molecular genetics of loline-alkaloid
production, originating from a preliminary hypoth-
esis of lolA and lolC being clustered (Spiering et al.
2005; US Patent 7183098, 2007). The question was
tackled with an impressive arsenal of up-to-date
techniques and ultimately resulted in the identifica-
tion of double homologs of nine genes similarly
arranged into two clusters, LOL-1 and LOL-2.
Long-range (LA: long and accurate) PCR and
parallel screening of a partial genomic library of
N. uncinatum to ascertain the existence of two highly
similar, yet distinct gene clusters. Extensive genome
walking into unknown regions yielding a total of 25
kb sequenced from LOL-1 and 16 kb from LOL-2.
Gene-prediction searches with the FGENESH pro-
gramme (available from: http://www.softberry.com/
berry.phtml) aided by RACE (rapid amplification of
cDNA ends) and confirmed by reverse transcription-
PCR based expression verification for identifying and
mapping ORFs (open reading frames). Large-scale
utilization of Basic Local Alignment Search Tool
(NCBI) to ascribe the putative functions of the
enzymatic entities encoded by the nine lol genes.
And, last but definitely not least, the very first
attempt of gene silencing by RNAi (RNA interfer-
ence) performed on a mutualistic fungus, providing
direct and indisputable evidence for involvement of
lolC in loline biosynthesis.
All in all, an unprecedented endeavor leading to a
final conclusion that the products of the lol genes thus
identified may be sufficient for the biosynthesis of the
entire loline-alkaloid three-ring structure in Neoty-
phodium uncinatum, from the primary precursor
amino acids, L-proline and L-homoserine (Figure
11) (Blankenship et al. 2005; Spiering et al. 2005).
As spectacular as it may seem, the aforementioned
accomplishment did not put a closure to solving the
riddle of endophytic lolines. On the contrary, it
contributed to further identification of single LOL
gene clusters in Epichloe¨ festucae, Neotyphodium sp.
PauTG-1 and Neotyphodium coenophialum (Kutil et
al. 2007).
To analyze the genetic architecture and to predict
the evolutionary history of LOL, the five character-
ized clusters were compared by means of the coupled
powers of phylogenetic approaches and other forms
of sequence analysis. All lol genes anchored to the
map for each species turned out to occur in strictly
conserved order and orientation (Figure 12).
Furthermore, PhyloCon-based (Wang and
Stormo 2003) comparison of the putative lol gene
promoter regions yielded the identification of four
motifs conserved across the genes in all five clusters,
with each motif having significant similarity to
known fungal transcription factor binding sites in
the TRANSFAC database (Wingender et al. 1996).
Conservation of these motifs further supported the
hypothesis of the lol genes being co-regulated (Spier-
ing et al. 2002, 2005).
Interestingly, the history of asexual Neotyphodium
spp. includes multiple interspecific hybridization
events (Tsai et al. 1994; Schardl 2001; Clay and
Schardl 2002; Moon et al. 2004). Thus, comparing the
clusters from three seed-transmitted Neotyphodium
anamorphs and their sexual counterpart, E. festucae,
allowed determining which Epichloe¨ ancestors were
the most likely contributors of LOL in these asexual
loline synthesizers. Perhaps the most striking out-
come of this comparative analysis was that three
Neotyphodium species with a history of Epichloe¨
typhina as an ancestor possess nearly identical copies
of LOL clusters (N. uncinatum LOL-2, N. coenophia-
lum, N. sp. PauTG-1). This is most remarkable in
light of the fact that there are no known isolates ofFigure 10. Loline.
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the extant species E. typhina which express loline
alkaloids (Leuchtmann et al. 2000). Thus, these data
support a model of evolution in which the poly-
morphism in loline alkaloid production phenotypes
among endophytic species is likely due to the loss of
the trait over time (Kutil et al. 2007).
Ergopeptines
Ergot alkaloids are produced by ascomycetous fungi
from discontinuous taxonomic groupings, including
plant-associated fungal genera from the family Cla-
vicipitaceae and some members of the order Euro-
tiales, including the human pathogen Aspergillus
fumigatus (Panaccione 2005). Due to their long
biotechnological tradition, with manifold applica-
tions in therapy (Tudzynski et al. 2001), the physiol-
ogy and biochemistry of ergopeptine formation have
been studied in minute detail (Floss 1976; Socic and
Gaberc-Porekar 1992; Gro¨ger and Floss 1998).
Nevertheless, an uncomfortable premonition of scar-
Figure 11. The loline alkaloid biosynthetic pathway (Blankenship et al. 2005).
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city in knowledge about the genetics of the biosyn-
thetic route leading to these valuable alkaloids
seemed to have arisen.
Yet again, the dynamic progress in the field of
molecular genetics proved invaluable. The first step
towards revealing the molecular background of ergo-
peptine biosynthesis was taken: the gene coding for
dimethylallyl tryptophan synthase (DMATS)  the
committed enzyme of the synthetic process in question
(Figure 13a)  was cloned via reverse genetics (Tsai et
al. 1995), identified by a differential cDNA screening
approach (Arntz and Tudzynski 1997) and character-
ized initially for Claviceps fusiformis, subsequently for
Claviceps purpurea (Tudzynski et al. 1999), and finally
for the phylogenetically distant Aspergillus fumigatus
(Coyle and Panaccione 2005; Unso¨ld and Li 2005; Li
and Unso¨ld 2006).
Fuelled by the conviction of secondary metabolite
pathway genes clustering in fungal genomes (Keller
and Hohn 1997), large-scale studies have been taken
up, resulting in the identification of gene clusters for
ergot alkaloid biosynthesis in C. purpurea (Tudzynski
et al. 1999; Correia et al. 2003; Haarmann et al. 2005,
2006) and A. fumigatus (Coyle and Panaccione 2005;
Unso¨ld and Li 2005; Li and Unso¨ld 2006); they
contain 13 and 14 genes, respectively. It has been
recently hypothesized that the fundamental ability to
synthesize some type of ergot alkaloid was present in
the most recent common ancestor of these Ascomy-
cetes, accounting for the current phylogenetically
discontinuous distribution of these secondary
metabolites (Panaccione 2005). Thus, genes shared
between the two clusters are presumed to be respon-
sible for the early steps common to the two organisms
(Coyle and Panaccione 2005).
The impressive achievements described hitherto,
have been successfully conveyed into the realm of
clavicipitaceous endophytic ergopeptine producers.
DMATS, as a gene encoding for the enzymatic entity
indispensable for ergot alkaloid production, was
characterized for Neotyphodium lolii harbored by
perennial ryegrass. Once the putative endophyte
homolog was identified by degenerate PCR, its
function was tested by gene knockout. Subsequent
complementation experiments resulted in the ultimate
confirmation of the postulated role of DMATS in the
biosynthetic process in question (Wang et al. 2004).
Analogous experimental procedure allowed for the
characterization of two consecutive genes, displaying
the capacity to encode nonribosomal peptide synthe-
tases (NRPS), namely: lpsA (Pannacione et al. 2001,
2003) and lpsB (Tanaka et al. 2005; Fleetwood et al.
2007), playing a vital role in the ergopeptine forma-
tion (Figure 13b) (Riederer et al. 1996; Walzel et al.
1997; Correia et al. 2003). The ultimate objective: to
determine whether ergot alkaloid biosynthetic genes
were clustered in Neotyphodium lolii was pursued by
using chromosome walking and Southern blot ana-
lysis and successfully attained (Fleetwood et al. 2007).
Interestingly, while gene sequence is relatively
highly conserved between each of the three thus far
identified ergot alkaloid gene clusters, there are several
differences in gene order and the N. lolii cluster (EAS)
seems to be more complex in structure and organiza-
tion, as compared to its pathogenic counterparts
(Figure 14). What is more, the BLASTN (NCBI) and
MEME (Multiple EM for Motif Elicitation) (Bailey
and Elkan 1994) analyses of the EAS cluster revealed
that its genes are closely associated with transposon
relics, including retrotransposons and autonomous as
well as non-autonomous DNA transposons.
Finally, it has been shown that ergot alkaloids are
specifically produced during biotrophic growth of
Epichloe¨ endophytes (Tanaka et al. 2005). Attendant
with this, the eas genes proved all to be expressed in
planta, while giving no evidence for expression under
axenic culture conditions. These results suggest that
specific plant environment may be required for the
induction of ergopeptine biosynthetic genes in the
fungal endophyte (Fleetwood et al. 2007).
Notably, ergot alkaloids have also been consid-
ered to constitute a chemotaxonomic signature of
Figure 12. Comparative maps of LOL gene cluster(s) from four endophyte species; the shaded boxes in the E. festucae map
indicate regions with homology to pol proteins; disconnected contig lines indicate genes that are sequenced, but not anchored
to other lol genes; the contig of sequence known for this region in E. festucae continues beyond the boundaries shown; arrows
along the bottom of the diagram indicate locations of putative promoter regions analyzed in the motif analysis (Kutil et al.
2007).
Journal of Plant Interactions 83
Convolvulaceae plants. However, recent studies on
Ipomoea asarifolia, a representative of this dicotyle-
doneous plant family, indicated that the accumula-
tion of the natural products in question depends, in
fact, on the presence of a plant-associated clavicipi-
taceous fungus. Thus, it has been postulated that
ergopeptines are not typical of the Ascomycota, the
Poaceae or the Convolvulaceae alone, but, in contrast,
they are very likely to prove a trait of a clavicipitac-
eous fungal taxon capable of colonizing certain
Figure 13. The ergot alkaloid biosynthetic pathway; biosynthesis of lysergic acid (a) and further ergopeptine formation, as
exempliﬁed by ergotamine (b) (Tudzynski et al. 1999, 2001).
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higher plants in mutualistic symbiosis (Kucht et al.
2004; Steiner et al. 2006).
Lolitrems
Indole-diterpenes are a large, structurally diverse
group of natural products commonly found in
filamentous fungi of the genera Penicillium, Aspergil-
lus and Claviceps (Mantle 1987; Parker and Scott
2004). Many of these compounds are potent
mammalian tremorgenic mycotoxins (Steyn and
Vleggaar 1985) and fall into four major structural
classes, namely the penitrems, janthitrems, paspali-
trems and lolitrems (Figure 15) (Mantle and Weedon
1994). They all share a common structural core
comprised of a cyclic diterpene skeleton derived
from geranylgeranyl diphosphate (GGPP) and an
indole moiety derived from tryptophan, while differ-
ent patterns of prenylation, hydroxylation, epoxyda-
tion and acetylation, and differences in ring
stereochemistry around the basic indole-diterpene
ring structure, are to be accountable for their
structural diversity (Parker and Scott 2004). The
best known of these fungal tremorgens are the
lolitrems produced by Epichloe¨ endophytes in asso-
ciation with temperate forage grasses (Gallagher et al.
1984).
The history of unravelling the molecular genetics
underlying endophytic lolitrem production seems to
encompass some of the elements of both the afore-
mentioned biosynthetic puzzles of microbial alka-
loids.
Initially, employing Penicillium paxilli as a
model experimental system to dissect the biochem-
istry of indole-diterpene biosynthesis (Young et al.
2001) (an obvious parallel can be drawn with the
ergots and their model synthesizer: Claviceps pur-
purea) allowed for the isolation of three orthologous
genes from the grass endophytes, Neotyphodium lolii
and Epichloe¨ festucae, and subsequent confirmation
of their contiguous clustering (Young et al. 2005).
While further attempts to clone additional linked
ltm genes in the endophytes by such approaches as
inverse PCR were thwarted by the presence of large
blocks of highly repetitive retrotransposon se-
quences flanking both sides of the cluster, an
alternative strategy combining suppression subtrac-
tive hybrydization (a technique applied successfully
in case of LOL characterization) with chromosome
walking was taken up. As a result, two additional
LTM gene clusters were identified and consequently
proved to be linked with LTM-1 (Young et al.
2006).
Ultimately, it has been shown that the genes for
lolitrem biosynthesis in the endophytic anamorph
Neotyphodium lolii form a complex genetic locus of at
least three LTM gene clusters (Figure 16). What is
more, the structure and organization of the said
endophytic locus, as compared to the orthologous
clusters from Penicillium paxilli (Young et al. 2001)
and Aspergillus flavus (Zhang et al. 2004), has yet
again proved to be of greater complexity (accord-
ingly: EAS clusters of pathogenic vs. endophytic
origin).
As sub-telomers are proposed to be ‘a workshop
of evolutionary genomic experimentation’ (Wong
and Wolfe 2005), it has been suggested that the
elaborate nature of the cluster in question may be
accounted for by its location in such a rapidly
evolving region of the endophytic genome (Gardner
et al. 2002; Kellis et al. 2003; Machida et al. 2005;
Nierman et al. 2005), and consequently driven by
recombination and mutational processes associated
with Type I transposon elements (Kempken and
Ku¨ck 1998) combined with the phenomenon of
repeat induced point mutation (RIP) (Selker et al.
1987).
Thus, consecutive similarities between LTM and
EAS loci seem to be brought to light. Firstly, the
association of the genes composing both these
endophytic clusters with the transposon relics ap-
pears to be of considerable importance (Young et al.
2006; Fleetwood et al. 2007). The abundance of
these relic sequences adds to the evolutionary
potential of both clusters. It might also suggest
that the regulation at the level of chromatin may be
of consequence for ltm and eas genes, since chro-
matin remodelling as a method of coordinate gene
regulation has been proposed as a possible factor
causing selection pressure for secondary metabolite
genes to be clustered (Martienssen and Colot 2001;
Volpe et al. 2002; Bok and Keller 2004; Keller et al.
2005; Lee et al. 2005). Secondly, all ten genes
identified at the LTM locus, as well as each gene
Figure 14. Comparative eas gene order among C. purpurea (Cp), N. lolii (Nl) and A. fumigatus (Af); black arrows, genes
proposed to be required for ergot alkaloid synthesis, but not yet identiﬁed for N. lolii; light grey arrows, genes found in N. lolii
and C. purpurea, but not in A. fumigatus; dark grey arrows, genes found only in A. fumigatus; N. lolii dmaW, cloA and lpsA are
not shown, as their locations relative to EAS cluster are not known (Fleetwood et al. 2007).
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in EAS cluster, have been shown to be highly
expressed in planta, but only to a minimal extent
or not at all  in axenic mycelial cultures, strongly
suggesting that plant signalling is indispensable to
induce their expression (Young et al. 2006; Fleet-
wood et al. 2007). However, the specific host stimuli
required for the activation of the fungal genes
remain to be identified.
Simultaneously, the aforementioned common
traits underlying the ergopeptine and lolitrem biosyn-
Figure 15. Proposed metabolic grid for indole-diterpenoid metabolites of particular species of Acremonium, Aspergillus,
Claviceps and Penicillium linked according to sequential transformation in the diterpenoid moiety (Mantle and Weedon 1994).
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thetic processes seem to emphasize the ultimate
uniqueness of lolines.
Maytansinoids from bacterial endophytes
As a matter of principle, hereby the elucidation of
molecular background underlying the clustering of
prokaryotic genes in the realm of endophytic second-
ary metabolism is shortly depicted. Thus, encompass-
ing the diversity of microbial endophytic world, as
well as acknowledging the early foundations set to
boost the gene clustering investigation per se will be
attempted.
The remarkable antitumor potency of maytansi-
noids, as well as the mystery surrounding their
biosynthetic and evolutionary origins was reflected
upon previously. It is noteworthy, however, that
these 19-membered macrocyclic lactams are closely
related to ansamycin antibiotics of microbial origin,
such as rifamycin B and geldanamycin (Rinehart and
Shield 1976). In fact, the aforementioned similarity
stimulated a search for maytansinoid-producing mi-
croorganisms, ultimately leading to the isolation of
ansamitocins (Figure 17) from the Actinomycetes,
Actinosynnema pretiosum ssp. pretiosum and a mutant
strain Actinosynnema pretiosum ssp. auranticum (Hi-
gashide et al. 1977; Asai et al. 1978).
The drive at the elucidation of microbial maytan-
sinoids biosynthesis at the biochemical and genetic
level was based upon the coupled forces of hetero-
logous hybridization and PCR. The primary aim was
to identify the gene encoding for the key enzyme in
the assembly of 3-amino-5-hydroxybenzoic acid
(AHBA) as the starter unit. Cloning by reverse
genetics of the AHBA synthase from Amycolatopsis
mediterranei (Kim et al. 1998) provided the necessary
probe and set the pace for identification, isolation
and sequencing of the consecutive entities embedded
in the biosynthetic gene cluster in question. A total of
250 kb of contiguous DNA was cloned and mapped.
The appropriate gene inactivations were carried out
to address the essential role of the AHBA gene
homologues and to define the boundary of the
biosynthetic locus (Yu et al. 2002). Notably, the
ansamitocin synthesis genes (asm) turned out to be
contained not in one, but two clusters in the
Actinosynnema pretiosum genome (Figure 18). This
separation of genes encoding the biosynthesis of a
given antibiotic into two essential clusters is unpre-
cedented in Prokaryota. Thus, it is proposed to be
merely an inconsequential accident resulting from an
evolutionary gene rearrangement which inserted 30
kb of non-essential DNA into the otherwise contig-
uous cluster (Yu et al. 2002).
Thus equipped with the essential genetic informa-
tion and modern tools to manipulate the biosynthetic
machinery, as well as urged by the extraordinary
therapeutic potential, the research on microbial
maytansinoids has recently entered a novel combina-
torial stage. Two principal approaches are being
explored. On one hand, the expression of all the
asm genes, assembled into several cassettes in a
heterologous host, such as Streptomyces coelicolor
or S. lividans is being considered. This approach
seems most promising in terms of elucidating the
detailed biosynthetic process, but it has some major
practical drawbacks, as the product titres are likely to
be very low. On the other hand, it has been proposed
to engineer mutations in the asm in the parent
Figure 16. A physical map of the N. lolii LTM locus; the boundaries of the three ltm gene clusters are identiﬁed by boxes
numbered 13; the genes, abbreviated to a single letter, are shown as arrows indicating the direction they are transcribed, with
the exon structure shown as black blocks underneath each gene; the blocks between ltm clusters 2 and 3 show the positions of
two imperfect direct repeats; the retrotransposon relics, Tahi and Rua, are identiﬁed by blocks above the sequence; the AT
content of each region is indicated as a percentage at the bottom of the ﬁgure; the distance across the sequence, shown
immediately below the genes, is represented in kb; the sequence containing ltm clusters 2 and 3 is separated from ltm cluster 1
by 35 kb (Young et al. 2006).
Figure 17. Ansamitocin P-3.
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producer organism. This alternative approach has the
advantage of all the regulatory elements and resis-
tance mechanisms required for ansamytocin forma-
tion being present and functional (Cassady et al.
2004).
Undoubtedly challenging prospects, with substan-
tial problems to be overcome and much more work
needed, yet bearing a considerable potential for
future drug discovery, optimization and production
processes (Floss 2006).
In summary, the accomplishments thus described
might prove to become a vital platform and a
blueprint for detailed studies of endophytic microbes
en mass  their biosynthetic networks, evolutionary
implications, host interdependencies, ecological,
pharmaceutical and industrial significance  in the
modern era of metabolic engineering and combina-
torial biosynthesis (Stephanopoulos et al. 2004; Floss
2006).
Concluding remarks and future perspectives
Biodiversity: a precious source of novelty. Not only in
terms of unravelling numerous mysteries of nature 
discovering a plethora of yet undescribed species,
their evolutionary backgrounds, genetics and ecol-
ogy, as well as the richness of thus implied new,
potentially valuable molecules; but also a revolution
of thought  an expended view promising to trans-
form glimpses of reductionist research of the past
years into snapshots of a dynamic world of systems
biology, where cells grow, divide and produce, or
organisms develop, differentiate and begin to deviate
from the norm (Kate and Laird 2000; Stephanopou-
los et al. 2004; Kayser and Quax 2007). Endophytic
microbes seem to fit perfectly into this natural
‘warehouse’, only a small part of which we have
been able to tap into so far.
The recent ‘genomics revolution’ has given mo-
mentum to considerable progress in the development
of new technologies in bioscience, addressing specifi-
cally the arena of natural product biosynthesis.
Whole-genome sequence mining (Lautru et al. 2005)
and genome scanning as an alternative approach,
providing an efficient way to discover natural pro-
duct biosynthetic gene clusters without having the
complete genome sequence (Zazopoulos et al. 2003);
advances in microbial cell fermentation technology
(Zengler et al. 2005; Weuster-Botzl et al. 2007) and
metagenomics as a valuable alternative offering a
cultivation-independent approach (Schloss and Han-
delsman 2005); ample successes in heterologous
expression and metabolic engineering (among many
others: Alper et al. 2005; Schmidt et al. 2005; Wenzel
et al. 2005; DeJong et al. 2006; Julsing et al. 2006;
Li et al. 2006; Lindahl et al. 2006; Nims et al. 2006;
Ro et al. 2006), the latter being in fact perceived as a
progenitor of functional genomics and systems biol-
ogy (Stephanopoulos et al. 2004; Tyo et al. 2007)  to
name only a few highlights.
As hereby reviewed, some of the aforementioned
novel strategies have enabled penetration into the
previously inaccessible natural-product resources:
microbial endophytes. While one has to be mindful
that the problem we set out to address is several
orders of magnitude larger than those with which we
are familiar, no one can deny the opportunities that
now present themselves.
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